Giulio Ferrero1, Luca Maria Sconfienza2,3, Francesco Fiz4,5, Emanuele Fabbro1, Angelo Corazza6, Daniele Dettore7, Davide Orlandi8, Carlo Castellazzo9, Stefano Tornago9, Giovanni Serafini1. 1. Unit of Diagnostic and Interventional Radiology, Ospedale Santa Corona, Pietra Ligure, Italy. 2. Unit of Diagnostic and Interventional Radiology, IRCCS Istituto Ortopedico Galeazzi, Via Riccardo Galeazzi 4, 20161, Milan, Italy. io@lucasconfienza.it. 3. Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy. io@lucasconfienza.it. 4. Department of Internal Medicine, Università degli Studi di Genova, Genova, Italy. 5. Nuclear Medicine Unit, Department of Radiology, University of Tübingen, Tübingen, Germany. 6. Unit of Diagnostic and Interventional Radiology, IRCCS Istituto Ortopedico Galeazzi, Via Riccardo Galeazzi 4, 20161, Milan, Italy. 7. Università degli Studi di Genova, Genoa, Italy. 8. Unit of Radiology, Ospedale Evangelico Internazionale, Genova, Italy. 9. Orthopedics Unit, Ospedale Santa Corona, Pietra Ligure, Italy.
Abstract
OBJECTIVES: We used T2 mapping to quantify the effect of intra-articular hyaluronic acid administration (IAHAA) on cartilage with correlation to clinical symptoms. METHODS: One hundred two patients with clinical and MRI diagnosis of hip or knee grade I-III chondropathy were prospectively included. All patients received a standard MRI examination of the affected hip/knee (one joint/patient) and T2-mapping multiecho sequence for cartilage evaluation. T2 values of all slices were averaged and used for analysis. One month after MR evaluation 72 patients (38 males; mean age 51±10 years) underwent IAHAA. As a control group, 30 subjects (15 males; 51 ± 9 years) were not treated. MR and WOMAC evaluation was performed at baseline and after 3, 9, and 15 months in all patients. RESULTS: T2 mapping in hyaluronic acid (HA) patients showed a significant increase in T2 relaxation times from baseline to the first time point after therapy in knees (40.7 ± 9.8 ms vs. 45.8 ± 8.6 ms) and hips (40.9 ± 9.7 ms; 45.9 ± 9.5 ms) (p < 0.001). At the 9- and 15-month evaluations, T2 relaxation dropped to values similar to the baseline ones (p < 0.001 vs. 3 month). The correlation between T2 increase and pain reduction after IAHAA was statistically significant (r = 0.54, p < 0.01) in patients with grade III chondropathy. CONCLUSIONS: T2 mapping can be used to evaluate the effect over time of IAHAA in patients with hip and knee chondropathy. KEY POINTS: • T2 relaxation times change over time after hyaluronic acid intra-articular administration • T2 relaxation times of the medial femoral condyle correlate with WOMAC variation • T2 relaxation times are different between Outerbridge I and II-III.
OBJECTIVES: We used T2 mapping to quantify the effect of intra-articularhyaluronic acid administration (IAHAA) on cartilage with correlation to clinical symptoms. METHODS: One hundred two patients with clinical and MRI diagnosis of hip or knee grade I-III chondropathy were prospectively included. All patients received a standard MRI examination of the affected hip/knee (one joint/patient) and T2-mapping multiecho sequence for cartilage evaluation. T2 values of all slices were averaged and used for analysis. One month after MR evaluation 72 patients (38 males; mean age 51±10 years) underwent IAHAA. As a control group, 30 subjects (15 males; 51 ± 9 years) were not treated. MR and WOMAC evaluation was performed at baseline and after 3, 9, and 15 months in all patients. RESULTS: T2 mapping in hyaluronic acid (HA) patients showed a significant increase in T2 relaxation times from baseline to the first time point after therapy in knees (40.7 ± 9.8 ms vs. 45.8 ± 8.6 ms) and hips (40.9 ± 9.7 ms; 45.9 ± 9.5 ms) (p < 0.001). At the 9- and 15-month evaluations, T2 relaxation dropped to values similar to the baseline ones (p < 0.001 vs. 3 month). The correlation between T2 increase and pain reduction after IAHAA was statistically significant (r = 0.54, p < 0.01) in patients with grade III chondropathy. CONCLUSIONS: T2 mapping can be used to evaluate the effect over time of IAHAA in patients with hip and knee chondropathy. KEY POINTS: • T2 relaxation times change over time after hyaluronic acidintra-articular administration • T2 relaxation times of the medial femoral condyle correlate with WOMAC variation • T2 relaxation times are different between Outerbridge I and II-III.
Authors: Alberto Aliprandi; Francesco Di Pietto; Paolo Minafra; Marcello Zappia; Simona Pozza; Luca Maria Sconfienza Journal: Radiol Med Date: 2013-11-26 Impact factor: 3.469
Authors: Richard Kijowski; Donna G Blankenbaker; Alejandro Munoz Del Rio; Geoffrey S Baer; Ben K Graf Journal: Radiology Date: 2013-01-07 Impact factor: 11.105
Authors: Michel D Crema; Frank W Roemer; Monica D Marra; Deborah Burstein; Garry E Gold; Felix Eckstein; Thomas Baum; Timothy J Mosher; John A Carrino; Ali Guermazi Journal: Radiographics Date: 2011 Jan-Feb Impact factor: 5.333
Authors: Gabby B Joseph; Charles E McCulloch; Jae Ho Sohn; Valentina Pedoia; Sharmila Majumdar; Thomas M Link Journal: Skeletal Radiol Date: 2021-11-04 Impact factor: 2.199